The abstract is read at the publisher; the summary is JClub's.
GAL is markedly downregulated in silent corticotroph adenomas, and GAL loss promotes tumor cell proliferation by activating PI3K-Akt-mTOR and increasing SREBP1 lipogenesis activity.
- Why it matters: Silent corticotroph adenomas are aggressive and recur frequently, yet their proliferation mechanisms and actionable metabolic vulnerabilities remain unclear.
- What they did: Using integrative bulk and single-cell RNA-seq plus GAL gain- and loss-of-function, the study combined RNA sequencing, luciferase reporter assays, lipidomics, and pharmacological inhibition, then tested SREBP1 blockade with fatostatin in vitro and in vivo.
- The result: Fatostatin reduced lipogenesis and significantly suppressed SCA growth in vitro and in vivo, supporting a MYCN-GAL-SREBP1 lipogenic axis as a druggable driver of proliferation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.